The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Canet Gerardo since 2005.
The trader's CIK number is 1054855.
At the time of the last reporting, Canet Gerardo was the Director of Dendreon Corp. (stock ticker symbol DNDN).
Also see all insider trading activities at Dendreon Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2012 | DNDN | 10,000 | $43,800 | 0 | $0 | 0 | $0 |
| 2011 | DNDN | 0 | $0 | 5,000 | $206,900 | 0 | $0 |
| 2010 | DNDN | 0 | $0 | 8,456 | $336,013 | 0 | $0 |
| 2009 | DNDN | 0 | $0 | 109,171 | $2,336,259 | 109,171 | $800,878 |
| 2007 | DNDN | 0 | $0 | 14,100 | $105,989 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2011 | INMD | 0 | $0 | 7,740 | $77,400 | 0 | $0 |
| 2009 | INMD | 0 | $0 | 2,000 | $18,560 | 0 | $0 |
| 2008 | INMD | 2,000 | $10,000 | 0 | $0 | 0 | $0 |
| 2007 | INMD | 0 | $0 | 10,000 | $117,500 | 0 | $0 |
| 2006 | INMD | 0 | $0 | 85,638 | $1,020,528 | 64,715 | $182,927 |
| 2005 | INMD | 0 | $0 | 91,881 | $898,232 | 0 | $0 |
2. Integramed America Inc (INMD)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-08-01 | DNDN | Buy | 10,000 | 4.38 | 43,800 |
| 2011-06-03 | DNDN | Sale | 5,000 | 41.38 | 206,900 |
| 2010-12-14 | DNDN | Sale | 4,456 | 36.32 | 161,837 |
| 2010-05-26 | DNDN | Sale | 4,000 | 43.54 | 174,176 |
| 2009-04-14 | DNDN | Option Ex | 109,171 | 7.34 | 800,878 |
| 2009-04-14 | DNDN | Sale | 109,171 | 21.40 | 2,336,259 |
| 2007-10-22 | DNDN | Sale | 14,100 | 7.52 | 105,989 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-06-03 | INMD | Sale | 195 | 10.00 | 1,950 |
| 2011-06-02 | INMD | Sale | 3,222 | 10.00 | 32,220 |
| 2011-06-01 | INMD | Sale | 4,323 | 10.00 | 43,230 |
| 2009-09-21 | INMD | Sale | 2,000 | 9.28 | 18,560 |
| 2008-12-05 | INMD | Buy | 1,000 | 5.00 | 5,000 |
| 2008-11-20 | INMD | Buy | 1,000 | 5.00 | 5,000 |
| 2007-06-14 | INMD | Sale | 10,000 | 11.75 | 117,500 |
| 2006-09-06 | INMD | Sale | 2,700 | 9.69 | 26,163 |
| 2006-09-07 | INMD | Sale | 1,347 | 9.59 | 12,917 |
| 2006-09-01 | INMD | Sale | 1,800 | 9.51 | 17,118 |
| 2006-09-05 | INMD | Sale | 4,500 | 9.51 | 42,795 |
| 2006-08-25 | INMD | Sale | 5,251 | 9.56 | 50,199 |
| 2006-08-21 | INMD | Sale | 902 | 9.53 | 8,596 |
| 2006-08-15 | INMD | Sale | 2,200 | 9.50 | 20,900 |
| 2006-08-11 | INMD | Sale | 2,000 | 9.50 | 19,000 |
| 2006-08-08 | INMD | Sale | 3,392 | 9.54 | 32,342 |
| 2006-03-21 | INMD | Option Ex | 3,169 | 4.60 | 14,577 |
| 2006-01-09 | INMD | Sale | 6,100 | 12.71 | 77,531 |
| 2006-01-09 | INMD | Option Ex | 6,100 | 2.31 | 14,078 |
| 2006-01-10 | INMD | Sale | 15,300 | 12.71 | 194,508 |
| 2006-01-10 | INMD | Option Ex | 15,300 | 2.31 | 35,312 |
| 2006-01-06 | INMD | Sale | 4,600 | 13.03 | 59,938 |
| 2006-01-05 | INMD | Sale | 10,000 | 13.18 | 131,800 |
| 2006-01-06 | INMD | Option Ex | 4,600 | 2.31 | 10,616 |
| 2006-01-05 | INMD | Option Ex | 10,000 | 2.74 | 27,390 |
| 2006-01-03 | INMD | Option Ex | 1,666 | 3.17 | 5,279 |
| 2006-01-04 | INMD | Option Ex | 23,880 | 3.17 | 75,675 |
| 2006-01-03 | INMD | Sale | 5,000 | 12.87 | 64,349 |
| 2006-01-04 | INMD | Sale | 20,546 | 12.77 | 262,372 |
| 2005-11-09 | INMD | Sale | 2,000 | 11.00 | 22,000 |
| 2005-11-04 | INMD | Sale | 8,000 | 11.16 | 89,320 |
| 2005-09-07 | INMD | Sale | 10,881 | 12.50 | 136,012 |
| 2005-08-12 | INMD | Sale | 51,000 | 8.90 | 453,900 |
| 2005-08-03 | INMD | Sale | 10,000 | 9.03 | 90,300 |
| 2005-05-25 | INMD | Sale | 10,000 | 10.67 | 106,700 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Canet Gerardo (Director of Dendreon Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.